
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
Jay Lenner2019-02-08T20:23:02+00:00
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Gallery
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.


IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?
Jay Lenner2019-02-08T20:16:30+00:00